Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

SkinBioTherapeutics finalises acquisition of Dermatronics

(Sharecast News) - SkinBioTherapeutics announced on Friday that it has finalised the acquisition of Dermatonics, known for its topical and dermatological products within the skincare and wound care sector. The AIM-traded firm said the acquisition was completed through an initial payment of £1.68m, with an additional £1.25m earn-out arrangement spanning three years.

It said the transaction was conducted on a cash-free and debt-free basis, with the necessary funds for the purchase secured through its new convertible bond facility.

"We are delighted to have completed the transaction with Dermatonics," said chief executive officer Stuart Ashman.

"As we said in the announcement yesterday, this acquisition aligns directly with the inorganic growth strategy we outlined in our full-year results last year."

Ashman said it was an accretive deal that would provide immediate benefits through synergies and accelerated routes to market.

"Our focus now is to integrate the two businesses and build value for our shareholders."

At 1546 GMT, shares in SkinBioTherapeutics were down 9.42% at 11.55p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Bluejay to broaden into helium and industrial gases
(Sharecast News) - Bluejay Mining announced a strategic decision to broaden its corporate scope, expanding into the exploration and development of helium, industrial gases, and hydrocarbons, on Friday.
Man Group's Q1 miss was temporary "roadbump", says Jefferies
(Sharecast News) - Shares in Man Group dropped on Friday after the investment management firm reported unexpected net outflows in the first quarter, but that didn't deter Jefferies from reiterating its 'buy' rating for the stock.
Vector Capital reports robust year-end financial position
(Sharecast News) - Commercial lender Vector Capital reported continued growth in shareholders' equity while maintaining dividends and implementing prudent bad debt provision policies in its full-year results on Friday.
Quadrise posts progress with Utah partner Valkor
(Sharecast News) - Quadrise updated the market on its collaboration with Valkor Technologies in Utah on Friday, targeting the supply of low sulphur 'MSAR' and 'bioMSAR' to the marine and power sector.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.